Vitamin D in clinically isolated syndrome: evidence for possible neuroprotection (Q41167369)

27 September 2017

title

Vitamin D in clinically isolated syndrome: evidence for possible neuroprotection (English)

1 reference

clinically isolated syndrome

27 September 2017

0 references

1 reference

E Waubant

1 reference

27 September 2017

E M Mowry

1 reference

27 September 2017

D Pelletier

1 reference

27 September 2017

Z Gao

1 reference

27 September 2017

M D Howell

1 reference

27 September 2017

S S Zamvil

1 reference

27 September 2017

publication date

31 October 2015

1 reference

European Journal of Neurology

27 September 2017

published in

1 reference

27 September 2017

1 reference

27 September 2017

1 reference

27 September 2017

page(s)

327-332

1 reference

Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis

27 September 2017

cites work

1 reference

Vitamin D status predicts new brain magnetic resonance imaging activity in multiple sclerosis

21 January 2018

1 reference

Inter-dependence of vitamin D levels with serum lipid profiles in multiple sclerosis.

21 January 2018

1 reference

Relapsing-remitting multiple sclerosis: sequential enhanced MR imaging vs clinical findings in determining disease activity

21 January 2018

1 reference

Gray matter atrophy and disability progression in patients with early relapsing-remitting multiple sclerosis: a 5-year longitudinal study

21 January 2018

1 reference

Rate of brain atrophy in benign vs early multiple sclerosis.

21 January 2018

1 reference

Gray matter atrophy correlates with MS disability progression measured with MSFC but not EDSS.

21 January 2018

1 reference

Progressive cerebral atrophy in multiple sclerosis. A serial MRI study

21 January 2018

1 reference

Gray matter atrophy in multiple sclerosis: a longitudinal study

21 January 2018

1 reference

Serial gadolinium-enhanced magnetic resonance imaging scans in patients with early, relapsing-remitting multiple sclerosis: Implications for clinical trials and natural history

21 January 2018

1 reference

21 January 2018

1 reference

Regional grey matter atrophy in clinically isolated syndromes at presentation

21 January 2018

1 reference

MRI dynamics of brain and spinal cord in progressive multiple sclerosis

21 January 2018

1 reference

Randomized controlled trial of atorvastatin in clinically isolated syndrome: the STAyCIS study

21 January 2018

1 reference

Vitamin D as an early predictor of multiple sclerosis activity and progression

21 January 2018

1 reference

Distribution of the vitamin D receptor and 1 alpha-hydroxylase in human brain

21 January 2018

1 reference

Protective effects of 1 alpha,25-(OH)(2)D(3) against the neurotoxicity of glutamate and reactive oxygen species in mesencephalic culture

21 January 2018

1 reference

Chronic vitamin D3 treatment protects against neurotoxicity by glutamate in association with upregulation of vitamin D receptor mRNA expression in cultured rat cortical neurons

21 January 2018

1 reference

Progesterone with vitamin D affords better neuroprotection against excitotoxicity in cultured cortical neurons than progesterone alone

21 January 2018

1 reference

Vitamin D and risk of cognitive decline in elderly persons

21 January 2018

1 reference

Sun exposure, vitamin D intake and progression to disability among veterans with progressive multiple sclerosis.

21 January 2018

1 reference

Effect of pretreatment vitamin d levels on in vivo effects of atorvastatin on bone metabolism in patients with heterozygous familial hypercholesterolemia

21 January 2018

1 reference

High Prevalence of Hypovitaminosis D Status in Patients With Early Parkinson Disease

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/ENE.12844

1 reference

27 September 2017

1 reference